Table 2 Elixhauser comorbidities and other comorbid conditions and medication use among Covid-19 -related hospitalizations

Congestive Heart Failure

11.02% (0.59)**

17.61% (0.13)**

Cardiac Arrhythmias

13.93% (0.70)**

24.69% (0.14)**

Valvular Disease

2.25% (0.28)**

3.99% (0.05)**

Pulmonary Circulation Disorders

3.78% (0.66)**

5.27% (1.28)**

Peripheral Vascular Disorders

2.87% (1.14)**

4.79% (0.48)**

Paralysis

1.78% (0.25)**

1.33% (0.02)**

Other Neurological Disorders

13.93% (2.96)**

17.15% (4.19)**

Uncomplicated Hypertension

37.05% (8.55)**

55.14% (13.65)**

Complicated Hypertension

14.69% (0.71)**

27.10% (0.16)**

Chronic Pulmonary Disease

22.33% (0.83)

22.11% (0.14)

Uncomplicated Diabetes

8.87% (0.55)**

14.80% (0.10)**

Complicated Diabetes

15.24% (0.70)**

26.27% (0.14)**

Hypothyroidism

4.07% (0.37)**

13.23% (0.10)**

Renal Failure

11.09% (0.61)**

21.05% (0.13)**

Liver Disease

8.51% (0.53)**

5.42% (0.06)**

Peptic Ulcer Disease without Bleeding

0.62% (0.15)**

0.31% (0.01)**

AIDS/HIV

1.31% (0.26)**

0.26% (0.01)**

Lymphoma

0.55% (0.14)

0.81% (0.02)

Metastatic Cancer

0.87% (0.18)

1.12% (0.02)

Solid Tumor Without Metastasis

1.75% (0.25)**

2.48% (0.60)**

Rheumatoid Arthritis/Collagen Vascular disorders

1.67% (0.23)**

2.94% (0.04)**

Coagulopathy

8.62% (0.55)**

12.14% (0.18)**

Obesity

20.51% (0.81)**

25.56 (0.22)**

Severe Obesity

10.98% (0.63)**

13.53% (0.11)**

Obesity with Complicated Diabetes

2.27% (0.05)**

5.61% (0.05)**

Weight Loss

5.31% (0.46)**

7.85% (0.13)**

Fluid & Electrolyte Disorders

40.11% (9.27)**

50.36% (12.43)**

Blood Loss Anemia

0.29% (0.10)**

0.45% (0.01)**

Deficiency Anemia

4.04% (0.40)

3.86% (0.05)

Alcohol Abuse

18.22% (0.77)**

2.53% (0.04)**

Drug Abuse

--

1.79% (0.04)

Psychoses

14.65% (0.87)**

2.47% (0.05)**

Depression

20.40% (0.82)**

11.62% (0.12)**

Remdesivir Administration

9.13% (0.58)**

22.91% (0.30)**

Baricitinib Administration

0.001 (8.03e-06)**

0.01 (0.002)**

Long-term Steroid Use

1.24% (0.21)**

1.74% (0.04)**

Long-term Anticoagulation

4.55% (0.40)**

9.56% (0.10)**

Long-term (Current) Drug Therapy

18.07% (0.88)

19.70% (0.46)

Long-Term NSAID

1.16% (0.21)

0.94% (0.03)

Long-Term Aspirin Use

7.49% (0.51)**

14.45% (0.19)**

History of Bariatric Surgery

0.52% (0.14)

0.73% (0.02)

Septic Shock

3.05% (0.33)**

7.33% (0.09)**

Cardiogenic Shock

0.62% (0.15)

0.63% (0.02)

Active Cannabis Abuse Disorder

92.07% (0.38)

--

Active Cannabis Dependence Disorder

5.85% (0.37)

--

Cannabis Abuse Remission

1.71% (0.26)

--

Cannabis Dependence Remission

0.36% (0.12)

--

APDRG 3&4

85.42% (0.72)**

94.29% (0.08)**

Elixhauser Sum ≥ 4

51.56% (1.05)

50.35% (0.23)

Covid-19 Primary Diagnosis

36.64% (1.02)**

60.37% (0.31)**

Covid-19 Diagnosis after Admission

63.36% (1.02)**

39.63% (0.31)**